Medical syringes are seen with Moderna company logo displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020. Jakub Porzycki | NurPhoto | Getty Images A key Food and Drug Administration advisory panel is scheduled to vote Thursday on whether to recommend …
Read More »FDA staff recommends watching for Bell’s palsy in Moderna and Pfizer vaccine recipients
Joel Saget | AFP | Getty Images U.S. Food and Drug Administration staff recommends monitoring people who get Pfizer or Moderna’s Covid-19 vaccine shots for possible cases of Bell’s palsy, saying it’s not necessarily a side effect but worth watching out for after a handful of trial participants got the …
Read More »Merck CEO optimistic, sees 6 more months of masks
Merck CEO Kenneth Frazier told CNBC on Thursday he was hopeful about continued progress on coronavirus vaccines but suggested that strict adherence to public-health protocols would remain necessary for months ahead. “I think there’s a lot of reason to be optimistic about the vaccines that are coming out. The Pfizer …
Read More »Why Pfizer's Covid vaccine has been authorized in the U.K. but not the U.S. yet
Pfizer had been submitting data on its vaccine on a “rolling basis” to the U.K., meaning regulators there were able to review the data in real-time.
Read More »Democrat on House antitrust panel sets sights on Big Pharma
After wrapping up a more than year-long investigation into Amazon, Apple, Facebook and Google, a top Democrat on the House Judiciary subcommittee on antitrust has his sights set on a new industry: Big Pharma. Rep. Joe Neguse, D-Colo., vice chairman of the subcommittee, is calling for a hearing to probe …
Read More »5 things to know before the stock market opens November 23, 2020
Here’s the most important news, trends and analysis that investors need to start their trading day: 1. Stock futures rise after positive news on Covid vaccine, treatments 2. AstraZeneca Covid vaccine shows up to 90% efficacy A test tube labelled vaccine is seen in front of AstraZeneca logo in this …
Read More »Merck acquires OncoImmune to ramp supply of promising Covid drug
Pharmaceutical giant Merck said it plans to acquire privately-held OncoImmune for $425 million in cash, gaining rights to an under-the-radar drug that’s shown striking results in hospitalized patients with Covid-19. The medicine, referred to as CD24Fc, was shown in a late-stage clinical study in September to reduce the risk of …
Read More »